- Home
- MMA vs NOTV Comparison
MMA vs NOTV Comparison
Compare MMA & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- NOTV
- Stock Information
- Founded
- MMA 2013
- NOTV 1974
- Country
- MMA Australia
- NOTV United States
- Employees
- MMA N/A
- NOTV N/A
- Industry
- MMA
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- NOTV Health Care
- Exchange
- MMA Nasdaq
- NOTV Nasdaq
- Market Cap
- MMA 38.9M
- NOTV 40.4M
- IPO Year
- MMA 2024
- NOTV 1997
- Fundamental
- Price
- MMA $1.97
- NOTV $2.73
- Analyst Decision
- MMA
- NOTV Strong Buy
- Analyst Count
- MMA 0
- NOTV 3
- Target Price
- MMA N/A
- NOTV $5.92
- AVG Volume (30 Days)
- MMA 85.2K
- NOTV 304.2K
- Earning Date
- MMA 11-19-2024
- NOTV 12-09-2024
- Dividend Yield
- MMA N/A
- NOTV N/A
- EPS Growth
- MMA N/A
- NOTV N/A
- EPS
- MMA N/A
- NOTV N/A
- Revenue
- MMA $375,175.00
- NOTV $501,062,000.00
- Revenue This Year
- MMA N/A
- NOTV N/A
- Revenue Next Year
- MMA N/A
- NOTV $8.69
- P/E Ratio
- MMA N/A
- NOTV N/A
- Revenue Growth
- MMA 45.19
- NOTV N/A
- 52 Week Low
- MMA $1.41
- NOTV $1.23
- 52 Week High
- MMA $5.25
- NOTV $11.42
- Technical
- Relative Strength Index (RSI)
- MMA N/A
- NOTV 64.06
- Support Level
- MMA N/A
- NOTV $1.71
- Resistance Level
- MMA N/A
- NOTV $3.60
- Average True Range (ATR)
- MMA 0.00
- NOTV 0.33
- MACD
- MMA 0.00
- NOTV 0.10
- Stochastic Oscillator
- MMA 0.00
- NOTV 54.69
About MMA Alta Global Group Limited
Alta Global Group Ltd is a technology company that is enabling the martial arts and combat sports industry to maximize the monetization opportunities available to the sector by increasing consumer participation in the sport and building upon existing community offerings within the sector. The Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.